To determine the potential of FAM20C inhibition as a disease modifying therapy for T2D, control and iAd-Fam20c–KO mice were fed HFD for 3 months to induce obesity and insulin resistance. Here, FAM20C is linked to obesity due to melanocortin 4 receptor deficiency.